• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population.

作者信息

González-Hormazábal Patricio, Castro Víctor G, Blanco Rafael, Gómez Fernando, Peralta Octavio, Waugh Enrique, Bravo Teresa, Reyes Jose M, Jara Lilian

出版信息

Breast Cancer Res Treat. 2008 Aug;110(3):543-5. doi: 10.1007/s10549-007-9743-0. Epub 2007 Sep 18.

DOI:10.1007/s10549-007-9743-0
PMID:17876702
Abstract
摘要

相似文献

1
Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population.
Breast Cancer Res Treat. 2008 Aug;110(3):543-5. doi: 10.1007/s10549-007-9743-0. Epub 2007 Sep 18.
2
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.CHEK2和BRCA2基因变异对乳腺癌风险的协同相互作用。
Breast Cancer Res Treat. 2009 Sep;117(1):161-5. doi: 10.1007/s10549-008-0249-1. Epub 2008 Nov 22.
3
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.用于乳腺癌风险临床评估的CHEK2*1100delC基因分型：对26000例患者病例和27000例对照的荟萃分析
J Clin Oncol. 2008 Feb 1;26(4):542-8. doi: 10.1200/JCO.2007.12.5922. Epub 2008 Jan 2.
4
CHEK2 1100delC and male breast cancer in the Netherlands.荷兰的 CHEK2 1100delC 与男性乳腺癌
Breast Cancer Res Treat. 2009 Jul;116(2):397-400. doi: 10.1007/s10549-008-0162-7. Epub 2008 Aug 31.
5
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America.北美遗传性乳腺癌家族中CHEK2*1100delC突变的缺失。
Cancer Genet Cytogenet. 2010 Oct 15;202(2):136-40. doi: 10.1016/j.cancergencyto.2010.07.124.
6
Increased risk of breast cancer associated with CHEK2*1100delC.携带CHEK2*1100delC与乳腺癌风险增加相关。
J Clin Oncol. 2007 Jan 1;25(1):57-63. doi: 10.1200/JCO.2005.05.5160. Epub 2006 Jul 31.
7
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.CHEK2*1100delC变异体在非BRCA1/BRCA2多病例家族中作为乳腺癌风险修饰因子发挥作用。
Cancer Res. 2003 Dec 1;63(23):8153-7.
8
German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.携带罕见CHEK2*1100delC的德国人群与早发性和家族性乳腺癌存在轻度关联。
Eur J Cancer. 2005 Dec;41(18):2896-903. doi: 10.1016/j.ejca.2005.04.049. Epub 2005 Oct 18.
9
CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.土耳其人群结直肠癌病例中不存在 CHEK2 1100delC、IVS2+1G>A 和 I157T 突变。
Cancer Epidemiol. 2012 Oct;36(5):453-7. doi: 10.1016/j.canep.2012.03.008. Epub 2012 Apr 20.
10
Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.患乳腺癌风险高的犹太裔德系东欧女性的种系CHEK2基因突变
Isr Med Assoc J. 2007 Nov;9(11):791-6.

引用本文的文献

1
Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population.BRCA1/2基因中的大型基因组重排以及CHEK2 1100delC等位基因变体对阿根廷人群乳腺癌/卵巢癌发生发展的作用。
Breast Cancer Res Treat. 2025 Apr;210(2):385-391. doi: 10.1007/s10549-024-07576-4. Epub 2024 Dec 20.
2
Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.拉美乳腺癌中 DNA 修复基因种系突变的全景：PARP 抑制剂和免疫疗法的机会。
Genes (Basel). 2019 Oct 10;10(10):786. doi: 10.3390/genes10100786.
3
Genetic Epidemiology of Breast Cancer in Latin America.
拉丁美洲乳腺癌的遗传流行病学。
Genes (Basel). 2019 Feb 18;10(2):153. doi: 10.3390/genes10020153.
4
Genetic Variants in pre-miR-146a, pre-miR-499, pre-miR-125a, pre-miR-605, and pri-miR-182 Are Associated with Breast Cancer Susceptibility in a South American Population.前体miR-146a、前体miR-499、前体miR-125a、前体miR-605和初级miR-182中的基因变异与南美人群的乳腺癌易感性相关。
Genes (Basel). 2018 Aug 22;9(9):427. doi: 10.3390/genes9090427.
5
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.中美洲和南美洲人群中BRCA1、BRCA2及其他乳腺癌和卵巢癌易感基因的突变
Biol Res. 2017 Oct 6;50(1):35. doi: 10.1186/s40659-017-0139-2.
6
An association study between CHEK2 gene mutations and susceptibility to breast cancer.CHEK2基因突变与乳腺癌易感性的关联研究。
Comp Clin Path. 2017;26(4):837-845. doi: 10.1007/s00580-017-2455-x. Epub 2017 Apr 8.
7
Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population.南美人群中Pre-miR-27a、Pre-miR-196a2、Pre-miR-423、miR-608和Pre-miR-618单核苷酸多态性与乳腺癌易感性的关联
BMC Genet. 2016 Jul 15;17(1):109. doi: 10.1186/s12863-016-0415-0.
8
The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.CHEK2基因1100delC等位变异在摩洛哥人群的家族性和散发性乳腺癌病例中不存在。
Springerplus. 2015 Feb 1;4:38. doi: 10.1186/s40064-014-0778-5. eCollection 2015.
9
Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.马来西亚乳腺癌患者多民族队列中CHEK2基因突变的低发生率。
PLoS One. 2015 Jan 28;10(1):e0117104. doi: 10.1371/journal.pone.0117104. eCollection 2015.
10
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.在中国高风险乳腺癌患者中发现的 CHEK2 Y390C 突变是一种新型的反复出现的突变，它削弱了 CHEK2 的活性，并与乳腺癌风险的增加相关。
Oncogene. 2015 Oct 1;34(40):5198-205. doi: 10.1038/onc.2014.443. Epub 2015 Jan 26.